Mavefund EN
Agilent Technologies Inc logo

Agilent Technologies Inc

A
Letzter Kurs (USD) US$152.87
Marktkapitalisierung (USD) US$37.9b
Kursänderung 12 Monate 21.63%
Loading the 12-month Mave Thesis and 1-month news signal

Start Heute Aktien Watchlist

Agilent Technologies Inc Überblick

Branche: Diagnostics & Research

Sektor: Healthcare

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California. Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromat

Research-Überblick

Letztes Berichtsdatum 2026-08-26

Diese Mavefund-Research-Seite bündelt geprüfte Informationen zu Agilent Technologies Inc (A): Unternehmensprofil, Kursverlauf, verknüpfte Primärquellen, verfügbare Finanzberichte, Research-Signale und zu prüfende Risiken.

Börsennotierung
A · NYSE · MIC XNYS
Land
United States
Handelswährung
USD
Branche
Diagnostics & Research
Finanzdaten
Jahres- und Zwischenabschlüsse verfügbar
Letzte Primärquelle
SEC EDGAR · veröffentlicht 2026-08-26
Primärquellen

Die Abdeckung wird automatisch aktualisiert und erst nach einer Datenintegritätsprüfung veröffentlicht. Nur Research-Unterstützung; keine persönliche Anlageberatung.

Mavefund ordnet die verfügbaren Fundamentaldaten, Bewertungskennzahlen und Risikofaktoren von Agilent Technologies Inc für einen nachvollziehbaren Research-Prozess ein.

Score

Veröffentlichte Ergebnisse

Was das Unternehmen berichtet hat – mit kompakter Quellenangabe.

Veröffentlicht Aug 26, 2026

Quarterly result summary

Revenue was $1.9B (reported); EPS was $1.62 (reported).

Revenue $1.9B reported
EPS $1.62 reported
Net income/share $1.28 reported
Income from operations $444M reported

Was sich verändert hat

  • Revenue reported to $1.9B; EPS reported to $1.62.
  • Operating income +23.6% YoY to $444M.

Guidance / outlook

No formal outlook was extracted from this filing excerpt. Open the source document to review full management commentary.

Earnings release Bericht öffnen

Source: SEC EDGAR company-filed earnings materials. Dates and source identifiers are retained for verification; review the original filing before relying on extracted report details.

Weitere aktuelle Ergebnisunterlagen

Geprüfte Signal-Evidenz

Aktuelle Nachrichten

Unternehmensrelevante Artikel aus Quellen, die die Relevanz- und Zuverlässigkeitsprüfung des Mave Signals bestehen.

Gewinn je Aktie

Score 4.00/5
Agilent Technologies Inc boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes Zoetis Inc IQVIA Holdings Inc Thermo Fisher Scientific Inc
In Diagnostics & Research industry , IQVIA Holdings Inc , Thermo Fisher Scientific Inc , Medpace Holdings Inc are companies with high ratings.

Eigenkapitalrendite

Score 4.56/5
Agilent Technologies Inc stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Zoetis Inc IQVIA Holdings Inc Thermo Fisher Scientific Inc
Agilent Tech... A US$37.9b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Thermo Fishe... TMO US$196.1b

Nettomarge

Score 4.84/5
Agilent Technologies Inc commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Zoetis Inc IQVIA Holdings Inc Thermo Fisher Scientific Inc
Agilent Tech... A US$37.9b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Thermo Fishe... TMO US$196.1b

Aktienrückkäufe

In Diagnostics & Research industry , IQVIA Holdings Inc , Thermo Fisher Scientific Inc , Medpace Holdings Inc are companies with high ratings.

Verschuldung

Score 1.97/5
Agilent Technologies Inc registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Zoetis Inc IQVIA Holdings Inc Thermo Fisher Scientific Inc have achieved high scores.
Agilent Tech... A US$37.9b
Zoetis Inc ZTS US$31.9b
IQVIA Holdin... IQV US$34.8b
Thermo Fishe... TMO US$196.1b

Finanzberichte

Vom Unternehmen veröffentlichte Berichtsdaten, strukturiert und mit der Originalquelle verknüpft.

Berichtswährung
Geprüfte, quellenverknüpfte Finanzberichte werden geladen, sobald dieser Abschnitt sichtbar wird.

Quellendetails werden mit den Berichtsdaten geladen. Die Werte sind standardisierte Unternehmensangaben zur Research-Unterstützung, keine persönliche Anlageberatung.

Finanzkennzahlen

Jährlich Quartalsweise

Finanzen
Profitabilität
Wachstum
Cashflow
Finanzielle Stabilität
Effizienzkennzahlen

Agilent Technologies Inc logo

Agilent Technologies Inc

US$152.87

US$57.14

-62.9% vs price

US$37.9b

-0.33%

21.63%